These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5905918)

  • 21. Electronic method of measuring and recording resistance to passive muscle stretch.
    RIEBEL JD; NASHOLD BS
    J Am Phys Ther Assoc; 1962 Jan; 42():21-8. PubMed ID: 14492136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of a new method of instrumental evaluation of the kinetic deficity in parkinsonism].
    Mutani R; Fariello R
    Riv Neurol; 1970; 40(3):165-73. PubMed ID: 5494149
    [No Abstract]   [Full Text] [Related]  

  • 23. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Montgomery EB
    Neurology; 2007 Jan; 68(2):164; author reply 164. PubMed ID: 17210906
    [No Abstract]   [Full Text] [Related]  

  • 24. [Method of measurement of akinesia].
    Joubert M; Barbeau A
    Union Med Can; 1966 May; 95(5):531-5. PubMed ID: 5932649
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Extrapyramidal" control of muscle tone: pathology].
    FERRARI E
    Riv Patol Nerv Ment; 1962 Jun; 83():299-304. PubMed ID: 13944833
    [No Abstract]   [Full Text] [Related]  

  • 26. [A clinico-MRI study of extrapyramidal symptoms in multiple system atrophy--linear hyperintensity in the outer margin of the putamen].
    Konagaya M; Konagaya Y; Honda H; Iida M
    No To Shinkei; 1993 Jun; 45(6):509-13. PubMed ID: 8363845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myotonic afterimages--a new type of afterimage].
    Smirnov VM; Medvedev SV; Puzenko VIu; Berezhkova LV
    Fiziol Cheloveka; 1985; 11(3):404-8. PubMed ID: 4054463
    [No Abstract]   [Full Text] [Related]  

  • 28. Changing concepts in Parkinson disease: moving beyond the decade of the brain.
    Bain PG
    Neurology; 2009 Feb; 72(6):579; author reply 579. PubMed ID: 19204276
    [No Abstract]   [Full Text] [Related]  

  • 29. Segmental versus suprasegmental contributions to long-latency stretch responses in man.
    Chan CW
    Adv Neurol; 1983; 39():467-87. PubMed ID: 6660105
    [No Abstract]   [Full Text] [Related]  

  • 30. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Suchowersky O; Gronseth G; Perlmutter J; Reich S; Zesiewicz T; Weiner WJ;
    Neurology; 2006 Apr; 66(7):976-82. PubMed ID: 16606908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain.
    Marras C; Lang A
    Neurology; 2008 May; 70(21):1996-2003. PubMed ID: 18490620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of parkinsonism and other extrapyramidal syndromes with a new thioxanthene derivative, Tremaril, as evaluated using Schwab's Parkinson Evaluation Sheet].
    Goto A; Watanabe T; Aoki T; Sugita T; Narabayashi H
    No To Shinkei; 1966 Jun; 18(6):645-53. PubMed ID: 6012478
    [No Abstract]   [Full Text] [Related]  

  • 33. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Montgomery EB
    Neurology; 2007 Jan; 68(1):81; author reply 81. PubMed ID: 16585044
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative cerebral and basal ganglia biopsy studies in extrapyramidal disorders.
    ROIZIN L; HOUSEPIAN E; POOL JL; ASAO H
    Trans Am Neurol Assoc; 1962; 87():132-5. PubMed ID: 13982492
    [No Abstract]   [Full Text] [Related]  

  • 35. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Aarsland D; Emre M; Lees A; Poewe W; Ballard C
    Neurology; 2007 Jan; 68(1):80; author reply 81. PubMed ID: 17200503
    [No Abstract]   [Full Text] [Related]  

  • 36. Postural and resting tremors in Parkinson's disease.
    Gresty MA; Findley LJ
    Adv Neurol; 1984; 40():361-4. PubMed ID: 6695612
    [No Abstract]   [Full Text] [Related]  

  • 37. Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease.
    Nyholm D; Kowalski J; Aquilonius SM
    Mov Disord; 2004 Apr; 19(4):446-51. PubMed ID: 15077243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study.
    Edwards L; Quigley EM; Hofman R; Pfeiffer RF
    Mov Disord; 1993; 8(1):83-6. PubMed ID: 8093549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reaction properties of muscle to passive shortening].
    Safronov VA
    Fiziol Cheloveka; 1984; 10(4):647-54. PubMed ID: 6530105
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of interactive effect of stretch reflex and shortening reaction on rigidity in Parkinson's disease.
    Xia R; Sun J; Threlkeld AJ
    Clin Neurophysiol; 2009 Jul; 120(7):1400-7. PubMed ID: 19487158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.